# Pharmacokinetic Interaction Study in Indonesian Tuberculosis Patients Indonesia

> **NCT00306319** · PHASE2 · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 23 (—)

## Conditions studied

- Tuberculosis

## Interventions

- **DRUG:** moxifloxacin

## Key facts

- **NCT ID:** NCT00306319
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2006-05
- **Final completion:** 2006-05
- **Target enrollment:** 23 (—)
- **Last updated:** 2020-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00306319

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00306319, "Pharmacokinetic Interaction Study in Indonesian Tuberculosis Patients Indonesia". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT00306319. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*